Abstract
INTRODUCTION: Persons living with HIV (PLWH) have an augmented risk of cardiovascular disease, including atherosclerosis and myocardial dysfunction, despite effective viral suppression with antiretroviral therapy (ART). Despite the majority of PLWH residing in sub-Saharan Africa, there are limited reports from the region on structural cardiovascular changes due to this residual risk. METHODS AND ANALYSIS: The Early Structural Cardiovascular Disease, HIV, and Tuberculosis (ASANTE) cross-sectional study will be conducted in a public hospital in Nairobi, Kenya. It will enroll 400 participants (50% female, 50% PLWH) to undergo comprehensive cardiovascular phenotyping using multimodal imaging (coronary CT angiography [CCTA], echocardiography) and banking of biological samples (whole blood, peripheral blood mononuclear cells, serum, and urine). We will define the prevalence of subclinical coronary atherosclerosis by coronary CT angiography (CCTA) and subclinical myocardial dysfunction by transthoracic echocardiography, and evaluate both traditional and non-traditional risk factors, including endemic infections such as latent tuberculosis. This study will contribute important data on phenotypes of and risk factors for HIV-associated cardiovascular disease in this under-studied region. ETHICS AND DISSEMINATION: Ethical approval for the ASANTE study was granted by the University of Nairobi-Kenyatta National Hospital Ethical Review Committee, Nairobi, Kenya. Results will be submitted for publication in peer-reviewed journals.